These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1407 related articles for article (PubMed ID: 8640068)
1. Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions. Steinbeck ZR; Heselmeyer KM; Gerlach B; Björnhagen V; Auer GU Melanoma Res; 1996 Feb; 6(1):37-43. PubMed ID: 8640068 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging. Pilch H; Günzel S; Schäffer U; Tanner B; Heine M Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry. Slater SD; Cook MG; Fisher C; Wright NA; Foster CS Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413 [TBL] [Abstract][Full Text] [Related]
4. DNA-cytophotometry of benign compound and intradermal naevi, Spitz epithelioid naevi and malignant melanomas. Lindholm C; Bjelkenkrantz K; Hofer PA Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(4):257-8. PubMed ID: 2890239 [TBL] [Abstract][Full Text] [Related]
5. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi. Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880 [TBL] [Abstract][Full Text] [Related]
6. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases. Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300 [TBL] [Abstract][Full Text] [Related]
7. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin. Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616 [TBL] [Abstract][Full Text] [Related]
8. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus. Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis. Casorzo L; Luzzi C; Nardacchione A; Picciotto F; Pisacane A; Risio M Melanoma Res; 2005 Jun; 15(3):155-60. PubMed ID: 15917696 [TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma--its precursors and its topography of proliferation. DNA-Feulgen-cytophotometry and mitosis index. Schmiegelow P; Schroiff R; Breitbart E; Bahnsen J; Lindner J; Jänner M Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):47-59. PubMed ID: 3085340 [TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148 [TBL] [Abstract][Full Text] [Related]
12. Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis. Winer I; Normolle DP; Shureiqi I; Sondak VK; Johnson T; Su L; Brenner DE Melanoma Res; 2002 Oct; 12(5):429-34. PubMed ID: 12394183 [TBL] [Abstract][Full Text] [Related]
13. Analysis of melanocytic lesions by DNA image cytometry. Schmidt B; Weinberg DS; Hollister K; Barnhill RL Cancer; 1994 Jun; 73(12):2971-7. PubMed ID: 8199994 [TBL] [Abstract][Full Text] [Related]
14. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity. Li LX; Crotty KA; Scolyer RA; Thompson JF; Kril JJ; Palmer AA; McCarthy SW Melanoma Res; 2003 Dec; 13(6):581-6. PubMed ID: 14646621 [TBL] [Abstract][Full Text] [Related]
15. Micro-anatomy related antigen expression in melanocytic lesions. Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983 [TBL] [Abstract][Full Text] [Related]
16. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma. Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299 [TBL] [Abstract][Full Text] [Related]
17. The approach to the patient with a difficult melanocytic lesion. Elder DE; Xu X Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112 [TBL] [Abstract][Full Text] [Related]
18. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers. Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720 [TBL] [Abstract][Full Text] [Related]
19. The flow cytometry of melanocytic skin lesions. Newton JA; Camplejohn RS; McGibbon DH Br J Cancer; 1988 Nov; 58(5):606-9. PubMed ID: 3219270 [TBL] [Abstract][Full Text] [Related]
20. Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties. Kanter L; Blegen H; Wejde J; Lagerlöf B; Larsson O Melanoma Res; 1995 Oct; 5(5):345-50. PubMed ID: 8541725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]